Finance

Lists
Why is KRRO down 2.27%?
Dive Deeper
KRRO:NASDAQ
Korro Bio Inc
$10.34
-2.27%
(-0.24) 1D
Oct 9, 2:42:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
$10.60
High
$10.78
Low
$10.28
Mkt. cap
152.26M
Avg. vol.
173.02K
Volume
76.96K
52-wk high
$55.89
52-wk low
$5.20
EPS
-$10.00
Beta
3.14
Shares outstanding
14.73M
No. of employees
57
Open
$10.60
High
$10.78
Low
$10.28
Mkt. cap
152.26M
Avg. vol.
173.02K
Volume
76.96K
52-wk high
$55.89
52-wk low
$5.20
EPS
-$10.00
Beta
3.14
Shares outstanding
14.73M
No. of employees
57
News stories
From web sources and news partners
About Korro Bio Inc
CEO-
Employees57
Founded2014
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 10 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current $10.34
$30.00 (+190.14%)
Average
$19.33 (+86.94%)
Lowest
$10.00 (-3.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$22.00
+112.8%
10/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$30.00
+190.1%
10/06/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$15.00
+45.1%
10/06/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
$21.00
+103.1%
10/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$22.00
+112.8%
10/06/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$21.00
+103.1%
09/09/2026
Luca Issi
RBC Capital
Hold
Maintained
$10.00
-3.3%
08/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$22.00
+112.8%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
$18.00
+74.1%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$15.00
+45.1%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
$23.00
+122.4%
05/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
$23.00
+122.4%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-1,656.97%
-3,873.22%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps